Navigation Links
Drugs Can Ease Juvenile Rheumatoid Arthritis
Date:11/9/2007

patients with JRA. The injectable drug blocks TNF-alpha, a protein that causes the pain and tenderness associated with rheumatic disease.

In this study, 42 JRA patients took etanercept for four years, and 26 of them continued to take it for eight years. Reasons for discontinuing use of the drug included: parental/guardian desire to remove patient from the study; poor treatment response; adverse effects, and a doctor's decision.

The study found that 23 percent of patients reported a total of 39 serious adverse events, but the overall rate of serious adverse events didn't increase with long-term use of the drug. There were no reported cases of lupus, demyelinating disorders, tuberculosis, malignancies, lymphomas, or deaths.

"The drug had a sustainable efficacy profile with a very beneficial safety profile. Only one serious infection, pyelonephritis (a kidney infection), was observed in the remaining patients during the past four years," investigator Dr. Andreas Reiff, head of the division of rheumatology, Keck School of Medicine, University of California, Children's Hospital Los Angeles, said in a prepared statement.

More information

The Nemours Foundation has more about juvenile rheumatoid arthritis.



-- Robert Preidt



SOURCE: American College of Rheumatology, news releases, Nov. 7, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. New review suggests caution on drugs to raise good cholesterol
2. Can cancer drugs combine forces?
3. Study provides hope that some transplant patients could live free of antirejection drugs
4. Study provides hope that some transplant patients could live free of anti-rejection drugs
5. RA Drugs Linked to Slight Skin Cancer Risk
6. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
7. Rock N Roll: Sex, Drugs and an Early Exit
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
10. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
11. 2 drugs equally effective for heart patients undergoing angioplasty, Mayo study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 1Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 2Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 3Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 4Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 5Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 6Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 7Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 8Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 9Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 10Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 11Nonin Medical Recognized for Influential Contributions in Medical Technology 5845 1Nonin Medical Recognized for Influential Contributions in Medical Technology 5845 2Neuro Kinetics 26amp 3B Military Researchers in Push To Improve Diagnosis 26amp 3B Treatment of Combat Brain Injuries 5842 1Neuro Kinetics 26amp 3B Military Researchers in Push To Improve Diagnosis 26amp 3B Treatment of Combat Brain Injuries 5842 2